MedTrace Logo

5E Program for Preventing Venous Thromboembolism in Patients With Spinal Cord Disorders

NCT06302478 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2024-03-13

No results posted yet for this study

Summary

The goal of this quasi-experimental study is to examine the effects of a venous thromboembolism prevention program, or "5E" program, on the rates of venous thromboembolism in patients with spinal cord disorders. The main questions it aims to answer are:

* Will participants receiving the 5E program have lower rates of venous thromboembolism compared to those receiving the usual care?
* Will participants receiving the 5E program have lower scores of venous thromboembolism signs and symptoms compared to those receiving the usual care?
* Will the average thigh and calf circumferences of participants before and after receiving the 5E program be different?

Participants in the intervention group will receive the 5E program, including

* Education: health education regarding venous thromboembolism prevention
* Elevation: leg elevation of 10-20 degrees
* Exercise: ankle exercises
* Enough fluid: adequate fluid uptake
* Early application of intermittent pneumatic compression (IPC): IPC use within 48 hours after admission

Conditions

  • Venous Thromboembolism
  • Spinal Cord Diseases
  • Spinal Cord Injuries
  • Nurse's Role

Interventions

BEHAVIORAL

5E program

Participants in the 5E program group will receive 7-day nursing interventions including * Education: health education regarding venous thromboembolism prevention * Elevation: leg elevation of 10-20 degrees * Exercise: ankle exercises * Enough fluid: adequate fluid uptake * Early application of intermittent pneumatic compression (IPC): IPC use within 48 hours after admission

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-12
Primary Completion
2024-05-30
Completion
2024-10-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06302478 on ClinicalTrials.gov